|
|
總筆數:54
| 篇名 | 作者 | 刊名 | 出版年 | 查看 |
|---|
| Conservative management of patients with acute myocardial infarctionand spontaneous acute patency of the infarct-related artery |
Steg, P.G.;Himbert, D.;Benamer, H.;Karrillon, G.;Boccara, A.;Aubry, P.;Juliard, J.M.; |
American Heart Journal |
1997-08-01 |
查看 |
| Elevated cardiac troponin I predicts a high-risk angiographic anatomyof the culprit lesion in unstable angina |
Benamer, H.;Steg, P.G.;Benessiano, J.;Vicaut, E.;Gaultier, C.J.;Aubry, P.;Boudvillain, O.;Sarfati, L.;Brochet, E.;Feldman, L.J.;Himbert, D.;Juliard, J.M.;Assayag, P.; |
American Heart Journal |
1999-05-01 |
查看 |
| Elevated cardiac troponin I predicts a high-risk angiographic anatomyof the culprit lesion in unstable angina |
Benamer, H.;Steg, P.G.;Benessiano, J.;Vicaut, E.;Gaultier, C.J.;Aubry, P.;Boudvillain, O.;Sarfati, L.;Brochet, E.;Feldman, L.J.;Himbert, D.;Juliard, J.M.;Assayag, P.; |
American Heart Journal |
1999-05-01 |
查看 |
| Elevated cardiac troponin I predicts a high-risk angiographic anatomyof the culprit lesion in unstable angina |
Benamer, H.;Steg, P.G.;Benessiano, J.;Vicaut, E.;Gaultier, C.J.;Aubry, P.;Boudvillain, O.;Sarfati, L.;Brochet, E.;Feldman, L.J.;Himbert, D.;Juliard, J.M.;Assayag, P.; |
American Heart Journal |
1999-05-01 |
查看 |
| Is direct coronary stenting the best strategy for long-term outcome?Results of the multicentric randomized benefit evaluation of directcoronary stenting (BET) study |
Elbaz, M.;El Mokhtar, E.;Khalife, K.;Citron, B.;Izaaz, K.;Hamon, M.;Juliard, J.M.;Leclercq, F.;Fourcade, J.;Lipiecki, J.;Sabatier, R.;Boulet, V.;Rinaldi, J.-P.;Mourali, S.;Fatouch, M.;Asmar, A.;Steg, P.G.;Puel, J.;Carrie, D.;BET Study Group; |
American Heart Journal |
2002-10-01 |
查看 |
| Is direct coronary stenting the best strategy for long-term outcome?Results of the multicentric randomized benefit evaluation of directcoronary stenting (BET) study |
Elbaz, M.;El Mokhtar, E.;Khalife, K.;Citron, B.;Izaaz, K.;Hamon, M.;Juliard, J.M.;Leclercq, F.;Fourcade, J.;Lipiecki, J.;Sabatier, R.;Boulet, V.;Rinaldi, J.P.;Mourali, S.;Fatouch, M.;Asmar, A.;Steg, P.G.;Puel, J.;Carrie, D.;BET Study Group; |
American Heart Journal |
2002-10-01 |
查看 |
| Low-molecular-weight heparin therapy for non-ST-elevation acutecoronary syndromes and during percutaneous coronary intervention: An expertconsensus^* |
Kereiakes, D.J.;Montalescot, G.;Antman, E.M.;Cohen, M.;Darius, H.;Ferguson, J.J.;Grines, C.;Karsch, K.R.;Kleiman, N.S.;Moliterno, D.J.;Steg, P.G.;Teirstein, P.;Van de Werf, F.;Wallentin, L.; |
American Heart Journal |
2002-10-01 |
查看 |
| Global patterns of use of antithrombotic and antiplatelet therapies inpatients with acute coronary syndromes: insights from the Global Registryof Acute Coronary Events (GRACE) |
Budaj, A.;Brieger, D.;Steg, P.G.;Goodman, S.G.;Dabbous, O.H.;Fox, K.A.A.;Avezum, A.;Cannon, C.P.;Mazurek, T.;Flather, M.D.;Van De Werf, F.;GRACE Investigators; |
American Heart Journal |
2003-12-01 |
查看 |
| Combined Abciximab REteplase Stent Study in acute myocardial infarction(CARESS in AMI) |
Di Mario, C.;Bolognese, L.;Maillard, L.;Dudek, D.;Gambarati, G.;Manari, A.;Guiducci, V.;Patrizi, G.;Rusconi, L.C.;Piovaccari, G.;Hibon, A.R.;Belpomme, V.;Indolfi, C.;Olivari, Z.;Steffenino, G.;Zmudka, K.;Airoldi, F.;Panzarasa, R.;Flather, M.;Steg, P.G.; |
American Heart Journal |
2004-09-01 |
查看 |
| A global view of atherothrombosis: Baseline characteristics in theClopidogrel for High Atherothrombotic Risk and Ischemic Stabilization,Management, and Avoidance (CHARISMA) trial |
on behalf of the CHARISMA Investigators;Bhatt, D.L.;Fox, K.A.;Hacke, W.;Berger, P.B.;Black, H.R.;Boden, W.E.;Cacoub, P.;Cohen, E.A.;Creager, M.A.;Easton, J.D.;Flather, M.D.;Haffner, S.M.;Hamm, C.W.;Hankey, G.J.;Johnston, S.C.;Mak, K.H.;Mas, J.L.;Montalescot, G.;Pearson, T.A.;Steg, P.G.;Steinhubl, S.R.;Weber, M.A.;Booth, J.;Topol, E.J.; |
American Heart Journal |
2005-09-01 |
查看 |
| A global view of atherothrombosis: Baseline characteristics in theClopidogrel for High Atherothrombotic Risk and Ischemic Stabilization,Management, and Avoidance (CHARISMA) trial |
on behalf of the CHARISMA Investigators;Bhatt, D.L.;Fox, K.A.;Hacke, W.;Berger, P.B.;Black, H.R.;Boden, W.E.;Cacoub, P.;Cohen, E.A.;Creager, M.A.;Easton, J.D.;Flather, M.D.;Haffner, S.M.;Hamm, C.W.;Hankey, G.J.;Johnston, S.C.;Mak, K.H.;Mas, J.L.;Montalescot, G.;Pearson, T.A.;Steg, P.G.;Steinhubl, S.R.;Weber, M.A.;Booth, J.;Topol, E.J.; |
American Heart Journal |
2005-09-01 |
查看 |
| A global view of atherothrombosis: Baseline characteristics in theClopidogrel for High Atherothrombotic Risk and Ischemic Stabilization,Management, and Avoidance (CHARISMA) trial |
on behalf of the CHARISMA Investigators;Bhatt, D.L.;Fox, K.A.;Hacke, W.;Berger, P.B.;Black, H.R.;Boden, W.E.;Cacoub, P.;Cohen, E.A.;Creager, M.A.;Easton, J.D.;Flather, M.D.;Haffner, S.M.;Hamm, C.W.;Hankey, G.J.;Johnston, S.C.;Mak, K.H.;Mas, J.L.;Montalescot, G.;Pearson, T.A.;Steg, P.G.;Steinhubl, S.R.;Weber, M.A.;Booth, J.;Topol, E.J.; |
American Heart Journal |
2005-09-01 |
查看 |
| The diagnostic and prognostic impact of the redefinition of acutemyocardial infarction: Lessons from the Global Registry of Acute CoronaryEvents (GRACE) |
for the GRACE Investigators;Goodman, S.G.;Steg, P.G.;Eagle, K.A.;Fox, K.A.A.;Lopez-Sendon, J.;Montalescot, G.;Budaj, A.;Kennelly, B.M.;Gore, J.M.;Allegrone, J.;Granger, C.B.;Gurfinkel, E.P.; |
American Heart Journal |
2006-03-01 |
查看 |
| The diagnostic and prognostic impact of the redefinition of acutemyocardial infarction: Lessons from the Global Registry of Acute CoronaryEvents (GRACE) |
for the GRACE Investigators;Goodman, S.G.;Steg, P.G.;Eagle, K.A.;Fox, K.A.A.;Lopez-Sendon, J.;Montalescot, G.;Budaj, A.;Kennelly, B.M.;Gore, J.M.;Allegrone, J.;Granger, C.B.;Gurfinkel, E.P.; |
American Heart Journal |
2006-03-01 |
查看 |
| The diagnostic and prognostic impact of the redefinition of acutemyocardial infarction: Lessons from the Global Registry of Acute CoronaryEvents (GRACE) |
for the GRACE Investigators;Goodman, S.G.;Steg, P.G.;Eagle, K.A.;Fox, K.A.A.;Lopez-Sendon, J.;Montalescot, G.;Budaj, A.;Kennelly, B.M.;Gore, J.M.;Allegrone, J.;Granger, C.B.;Gurfinkel, E.P.; |
American Heart Journal |
2006-03-01 |
查看 |
| The diagnostic and prognostic impact of the redefinition of acutemyocardial infarction: Lessons from the Global Registry of Acute CoronaryEvents (GRACE) |
for the GRACE Investigators;Goodman, S.G.;Steg, P.G.;Eagle, K.A.;Fox, K.A.A.;Lopez-Sendon, J.;Montalescot, G.;Budaj, A.;Kennelly, B.M.;Gore, J.M.;Allegrone, J.;Granger, C.B.;Gurfinkel, E.P.; |
American Heart Journal |
2006-03-01 |
查看 |
| The REduction of Atherothrombosis for Continued Health (REACH)Registry: An international, prospective, observational investigation insubjects at risk for atherothrombotic events-study design |
on behalf of the REACH Registry Investigators;Ohman, E.M.;Bhatt, D.L.;Steg, P.G.;Goto, S.;Hirsch, A.T.;Liau, C.S.;Mas, J.L.;Richard, A.J.;Rother, J.;Wilson, P.W.F.; |
American Heart Journal |
2006-04-01 |
查看 |
| The REduction of Atherothrombosis for Continued Health (REACH)Registry: An international, prospective, observational investigation insubjects at risk for atherothrombotic events-study design |
on behalf of the REACH Registry Investigators;Ohman, E.M.;Bhatt, D.L.;Steg, P.G.;Goto, S.;Hirsch, A.T.;Liau, C.S.;Mas, J.L.;Richard, A.J.;Rother, J.;Wilson, P.W.F.; |
American Heart Journal |
2006-04-01 |
查看 |
| How obesity affects the cut-points for B-type natriuretic peptide inthe diagnosis of acute heart failure |
Daniels, L.B.;Clopton, P.;Bhalla, V.;Krishnaswamy, P.;Nowak, R.M.;McCord, J.;Hollander, J.E.;Duc, P.;Omland, T.;Storrow, A.B.;Abraham, W.T.;Wu, A.H.B.;Steg, P.G.;Westheim, A.;Knudsen, C.W.;Perez, A.;Kazanegra, R.;Herrmann, H.C.;McCullough, P.A.;Maisel, A.S.; |
American Heart Journal |
2006-05-01 |
查看 |
| How obesity affects the cut-points for B-type natriuretic peptide inthe diagnosis of acute heart failure |
Daniels, L.B.;Clopton, P.;Bhalla, V.;Krishnaswamy, P.;Nowak, R.M.;McCord, J.;Hollander, J.E.;Duc, P.;Omland, T.;Storrow, A.B.;Abraham, W.T.;Wu, A.H.B.;Steg, P.G.;Westheim, A.;Knudsen, C.W.;Perez, A.;Kazanegra, R.;Herrmann, H.C.;McCullough, P.A.;Maisel, A.S.; |
American Heart Journal |
2006-05-01 |
查看 |
| How obesity affects the cut-points for B-type natriuretic peptide inthe diagnosis of acute heart failure |
Daniels, L.B.;Clopton, P.;Bhalla, V.;Krishnaswamy, P.;Nowak, R.M.;McCord, J.;Hollander, J.E.;Duc, P.;Omland, T.;Storrow, A.B.;Abraham, W.T.;Wu, A.H.B.;Steg, P.G.;Westheim, A.;Knudsen, C.W.;Perez, A.;Kazanegra, R.;Herrmann, H.C.;McCullough, P.A.;Maisel, A.S.; |
American Heart Journal |
2006-05-01 |
查看 |
| How obesity affects the cut-points for B-type natriuretic peptide inthe diagnosis of acute heart failure |
Daniels, L.B.;Clopton, P.;Bhalla, V.;Krishnaswamy, P.;Nowak, R.M.;McCord, J.;Hollander, J.E.;Duc, P.;Omland, T.;Storrow, A.B.;Abraham, W.T.;Wu, A.H.B.;Steg, P.G.;Westheim, A.;Knudsen, C.W.;Perez, A.;Kazanegra, R.;Herrmann, H.C.;McCullough, P.A.;Maisel, A.S.; |
American Heart Journal |
2006-05-01 |
查看 |
| How obesity affects the cut-points for B-type natriuretic peptide inthe diagnosis of acute heart failure |
Daniels, L.B.;Clopton, P.;Bhalla, V.;Krishnaswamy, P.;Nowak, R.M.;McCord, J.;Hollander, J.E.;Duc, P.;Omland, T.;Storrow, A.B.;Abraham, W.T.;Wu, A.H.B.;Steg, P.G.;Westheim, A.;Knudsen, C.W.;Perez, A.;Kazanegra, R.;Herrmann, H.C.;McCullough, P.A.;Maisel, A.S.; |
American Heart Journal |
2006-05-01 |
查看 |
| Rationale and design of a randomized, double-blind, placebo-controlledtrial of ivabradine in patients with stable coronary artery disease andleft ventricular systolic dysfunction: the morBidity-mortality EvAlUaTionof the I"f inhibitor ivabradine in patients with coronary disease and leftventricULar dysfunction (BEAUTIFUL) Study |
on behalf of the BEAUTIFUL Steering Committee;Fox, K.;Ferrari, R.;Tendera, M.;Steg, P.G.;Ford, I.; |
American Heart Journal |
2006-11-01 |
查看 |
| Patterns of use and potential impact of early @b-blocker therapy innon-ST-elevation myocardial infarction with and without heart failure: TheGlobal Registry of Acute Coronary Events |
for the GRACE Investigators;Emery, M.;Lopez-Sendon, J.;Steg, P.G.;Anderson, F.A.;Dabbous, O.H.;Scheuble, A.;Eagle, K.A.; |
American Heart Journal |
2006-12-01 |
查看 |
| Patterns of use and potential impact of early @b-blocker therapy innon-ST-elevation myocardial infarction with and without heart failure: TheGlobal Registry of Acute Coronary Events |
for the GRACE Investigators;Emery, M.;Lopez-Sendon, J.;Steg, P.G.;Anderson, F.A.;Dabbous, O.H.;Scheuble, A.;Eagle, K.A.; |
American Heart Journal |
2006-12-01 |
查看 |
| Patterns of use and potential impact of early @b-blocker therapy innon-ST-elevation myocardial infarction with and without heart failure: TheGlobal Registry of Acute Coronary Events |
for the GRACE Investigators;Emery, M.;Lopez-Sendon, J.;Steg, P.G.;Anderson, F.A.;Dabbous, O.H.;Scheuble, A.;Eagle, K.A.; |
American Heart Journal |
2006-12-01 |
查看 |
| Use of proven therapies in non-ST-elevation acute coronary syndromesaccording to evidence-based risk stratification |
for the GRACE Investigators;Oliveira, G.B.F.;Avezum, A.;Anderson, F.A.;Budaj, A.;Dabbous, O.H.;Goodman, S.G.;Steg, P.G.;Goldberg, R.J.;Brieger, D.;Fox, K.A.A.;Gore, J.M.;Granger, C.B.; |
American Heart Journal |
2007-04-01 |
查看 |
| Ethnic differences in the prevalence and treatment of cardiovascularrisk factors in US outpatients with peripheral arterial disease: Insightsfrom the Reduction of Atherothrombosis for Continued Health (REACH) Registry |
on behalf of the REACH Registry Investigators;Meadows, T.A.;Bhatt, D.L.;Hirsch, A.T.;Creager, M.A.;Califf, R.M.;Ohman, E.M.;Cannon, C.P.;Eagle, K.A.;Alberts, M.J.;Goto, S.;Smith, S.C.;Wilson, P.W.F.;Watson, K.E.;Steg, P.G.; |
American Heart Journal |
2009-12-01 |
查看 |
| Rationale and design of the Patient Related OuTcomes with Endeavorversus Cypher stenting Trial (PROTECT): Randomized controlled trialcomparing the incidence of stent thrombosis and clinical events aftersirolimus or zotarolimus drug-eluting stent implantation |
for the PROTECT Steering Committee and Investigators;Camenzind, E.;Wijns, W.;Mauri, L.;Boersma, E.;Parikh, K.;Kurowski, V.;Gao, R.;Bode, C.;Greenwood, J.P.;Gershlick, A.;O'Neill, W.;Serruys, P.W.;Jorissen, B.;Steg, P.G.; |
American Heart Journal |
2009-12-01 |
查看 |
| Can an elderly woman's heart be too strong? |
Saab, F.A.;Steg, P.G.;Avezum, A.;Lopez-Sendon, J.;Anderson, F.A.;Huang, W.;Eagle, K.A.; |
American Heart Journal |
2010-11-01 |
查看 |
| Fondaparinux with UnfracTionated heparin dUring Revascularization inAcute coronary syndromes (FUTURA/OASIS 8): A randomized trial ofintravenous unfractionated heparin during percutaneous coronaryintervention in patients with non-ST-segment elevation acute coronarysyndromes initially treated with fondaparinux |
Steg, P.G.;Mehta, S.;Jolly, S.;Xavier, D.;Rupprecht, H.J.;Lopez-Sendon, J.L.;Chrolavicius, S.;Rao, S.V.;Granger, C.B.;Pogue, J.;Laing, S.;Yusuf, S.; |
American Heart Journal |
2010-12-01 |
查看 |
| Design and rationale of the RadIal Vs. femorAL access for coronaryintervention (RIVAL) trial: A randomized comparison of radial versusfemoral access for coronary angiography or intervention in patients withacute coronary syndromes |
Jolly, S.S.;Niemela, K.;Xavier, D.;Widimsky, P.;Budaj, A.;Valentin, V.;Lewis, B.S.;Avezum, A.;Steg, P.G.;Rao, S.V.;Cairns, J.;Chrolavicius, S.;Yusuf, S.;Mehta, S.R.; |
American Heart Journal |
2011-02-01 |
查看 |
| The influence of time from symptom onset and reperfusion strategy on1-year survival in ST-elevation myocardial infarction: A pooled analysis ofan early fibrinolytic strategy versus primary percutaneous coronaryintervention from CAPTIM and WEST |
Westerhout, C.M.;Bonnefoy, E.;Welsh, R.C.;Steg, P.G.;Boutitie, F.;Armstrong, P.W.; |
American Heart Journal |
2011-02-01 |
查看 |
| Bleeding, mortality, and antiplatelet therapy: Results from theClopidogrel for High Atherothrombotic Risk and Ischemic Stabilization,Management, and Avoidance (CHARISMA) trial |
Berger, J.S.;Bhatt, D.L.;Steg, P.G.;Steinhubl, S.R.;Montalescot, G.;Shao, M.;Hacke, W.;Fox, K.A.;Berger, P.B.;Topol, E.J.;Lincoff, A.M.; |
American Heart Journal |
2011-07-01 |
查看 |
| Relationship of female sex to outcomes after myocardial infarction withpersistent total occlusion of the infarct artery: Analysis of the OccludedArtery Trial (OAT) |
Reynolds, H.R.;Forman, S.A.;Tamis-Holland, J.E.;Steg, P.G.;Mark, D.B.;Pearte, C.A.;Carvalho, A.C.;Sopko, G.;Liu, L.;Lamas, G.A.;Kruk, M.;Loboz-Grudzien, K.;Ruzyllo, W.;Hochman, J.S.; |
American Heart Journal |
2012-03-01 |
查看 |
| Reinfarction after percutaneous coronary intervention or medicalmanagement using the universal definition in patients with total occlusionafter myocardial infarction: Results from long-term follow-up of theOccluded Artery Trial (OAT) cohort |
White, H.D.;Reynolds, H.R.;Carvalho, A.C.;Pearte, C.A.;Liu, L.;Martin, C.E.;Knatterud, G.L.;Dzavik, V.;Kruk, M.;Steg, P.G.;Cantor, W.J.;Menon, V.;Lamas, G.A.;Hochman, J.S.; |
American Heart Journal |
2012-04-01 |
查看 |
| Design and rationale of the Treatment of Acute Coronary Syndromes withOtamixaban trial: A double-blind triple-dummy 2-stage randomized trialcomparing otamixaban to unfractionated heparin and eptifibatide innon-ST-segment elevation acute coronary syndromes with a planned earlyinvasive strategy |
Steg, P.G.;Mehta, S.R.;Pollack, C.V.;Bode, C.;Gaudin, C.;Fanouillere, K.;Moryusef, A.;Wiviott, S.D.;Sabatine, M.S.; |
American Heart Journal |
2012-12-01 |
查看 |
| Radial versus femoral access, bleeding and ischemic events in patientswith non-ST-segment elevation acute coronary syndrome managed with aninvasive strategy |
Klutstein, M.W.;Westerhout, C.M.;Armstrong, P.W.;Giugliano, R.P.;Lewis, B.S.;Gibson, C.M.;Lutchmedial, S.;Widimsky, P.;Steg, P.G.;Dalby, A.;Zeymer, U.;Van de Werf, F.;Harrington, R.A.;Newby, L.K.;Rao, S.V.; |
American Heart Journal |
2013-04-01 |
查看 |
| Rationale, design, and baseline characteristics of the Study assessInGthe morbidity-mortality beNefits of the I"f inhibitor ivabradine inpatients with coronarY artery disease (SIGNIFY trial): A randomized,double-blind, placebo-controlled trial of ivabradine in patients withstable coronary artery disease without clinical heart failure |
Fox, K.;Ford, I.;Steg, P.G.;Tardif, J.C.;Tendera, M.;Ferrari, R.; |
American Heart Journal |
2013-10-01 |
查看 |
| Design and methods of European Ambulance Acute Coronary SyndromeAngiography Trial (EUROMAX): An international randomized open-labelambulance trial of bivalirudin versus standard-of-care anticoagulation inpatients with acute ST-segment-elevation myocardial infarction transferredfor primary percutaneous coronary intervention |
Steg, P.G.;van 't Hof, A.;Clemmensen, P.;Lapostolle, F.;Dudek, D.;Hamon, M.;Cavallini, C.;Gordini, G.;Huber, K.;Coste, P.;Thicoipe, M.;Nibbe, L.;Steinmetz, J.;Ten Berg, J.;Eggink, G.J.;Zeymer, U.;Campo dell' Orto, M.;Kanic, V.;Deliargyris, E.N.;Day, J.;Schuette, D.;Hamm, C.W.;Goldstein, P.; |
American Heart Journal |
2013-12-01 |
查看 |
| Design and rationale of the TOTAL trial: A randomized trial of routineaspiration ThrOmbecTomy with percutaneous coronary intervention (PCI)versus PCI ALone in patients with ST-elevation myocardial infarctionundergoing primary PCI |
Jolly, S.S.;Cairns, J.;Yusuf, S.;Meeks, B.;Shestakovska, O.;Thabane, L.;Niemela, K.;Steg, P.G.;Bertrand, O.F.;Rao, S.V.;Avezum, A.;Cantor, W.J.;Pancholy, S.B.;Moreno, R.;Gershlick, A.;Bhindi, R.;Welsh, R.C.;Cheema, A.N.;Lavi, S.;Rokoss, M.;Dzavik, V.; |
American Heart Journal |
2014-03-01 |
查看 |
| Antiplatelet and anticoagulation agents in acute coronary syndromes:What is the current status and what does the future hold? |
Huber, K.;Bates, E.R.;Valgimigli, M.;Wallentin, L.;Kristensen, S.D.;Anderson, J.L.;Lopez Sendon, J.L.;Tubaro, M.;Granger, C.B.;Bode, C.;Ohman, E.M.;Steg, P.G.; |
American Heart Journal |
2014-11-01 |
查看 |
| How can we optimize the processes of care for acute coronary syndromesto improve outcomes? |
Wallentin, L.;Kristensen, S.D.;Anderson, J.L.;Tubaro, M.;Sendon, J.L.L.;Granger, C.B.;Bode, C.;Huber, K.;Bates, E.R.;Valgimigli, M.;Steg, P.G.;Ohman, E.M.; |
American Heart Journal |
2014-11-01 |
查看 |
| Effect of alirocumab, a monoclonal antibody to PCSK9, on long-termcardiovascular outcomes following acute coronary syndromes: Rationale anddesign of the ODYSSEY Outcomes trial |
Schwartz, G.G.;Bessac, L.;Berdan, L.G.;Bhatt, D.L.;Bittner, V.;Diaz, R.;Goodman, S.G.;Hanotin, C.;Harrington, R.A.;Jukema, J.W.;Mahaffey, K.W.;Moryusef, A.;Pordy, R.;Roe, M.T.;Rorick, T.;Sasiela, W.J.;Shirodaria, C.;Szarek, M.;Tamby, J.F.;Tricoci, P.;White, H.;Zeiher, A.;Steg, P.G.; |
American Heart Journal |
2014-11-01 |
查看 |
| Antiplatelet and anticoagulation agents in acute coronary syndromes:What is the current status and what does the future hold? |
Huber, K.;Bates, E.R.;Valgimigli, M.;Wallentin, L.;Kristensen, S.D.;Anderson, J.L.;Lopez Sendon, J.L.;Tubaro, M.;Granger, C.B.;Bode, C.;Ohman, E.M.;Steg, P.G.; |
American Heart Journal |
2014-11-01 |
查看 |
| How can we optimize the processes of care for acute coronary syndromesto improve outcomes? |
Wallentin, L.;Kristensen, S.D.;Anderson, J.L.;Tubaro, M.;Sendon, J.L.L.;Granger, C.B.;Bode, C.;Huber, K.;Bates, E.R.;Valgimigli, M.;Steg, P.G.;Ohman, E.M.; |
American Heart Journal |
2014-11-01 |
查看 |
| Effect of alirocumab, a monoclonal antibody to PCSK9, on long-termcardiovascular outcomes following acute coronary syndromes: Rationale anddesign of the ODYSSEY Outcomes trial |
Schwartz, G.G.;Bessac, L.;Berdan, L.G.;Bhatt, D.L.;Bittner, V.;Diaz, R.;Goodman, S.G.;Hanotin, C.;Harrington, R.A.;Jukema, J.W.;Mahaffey, K.W.;Moryusef, A.;Pordy, R.;Roe, M.T.;Rorick, T.;Sasiela, W.J.;Shirodaria, C.;Szarek, M.;Tamby, J.F.;Tricoci, P.;White, H.;Zeiher, A.;Steg, P.G.; |
American Heart Journal |
2014-11-01 |
查看 |
| Impact of diabetes mellitus and metabolic syndrome on acute and chronicon-clopidogrel platelet reactivity in patients with stable coronary arterydisease undergoing drug-eluting stent placement |
Feldman, L.;Tubach, F.;Juliard, J.M.;Himbert, D.;Ducrocq, G.;Sorbets, E.;Triantafyllou, K.;Kerner, A.;Abergel, H.;Huisse, M.G.;Roussel, R.;Esposito-Farese, M.;Steg, P.G.;Ajzenberg, N.; |
American Heart Journal |
2014-12-01 |
查看 |
| Rationale and design of the Cyclosporine to ImpRove Clinical oUtcome inST-elevation myocardial infarction patients (the CIRCUS trial) |
CIRCUS Study Investigators;Mewton, N.;Cung, T.T.;Morel, O.;Cayla, G.;Bonnefoy-Cudraz, E.;Rioufol, G.;Angoulvant, D.;Guerin, P.;Elbaz, M.;Delarche, N.;Coste, P.;Vanzetto, G.;Metge, M.;Aupetit, J.F.;Jouve, B.;Motreff, P.;Tron, C.;Labeque, J.N.;Steg, P.G.;Cottin, Y.;Range, G.;Clerc, J.;Coussement, P.;Prunier, F.;Moulin, F.;Roth, O.;Belle, L.;Dubois, P.;Barragan, P.;Gilard, M.;Piot, C.;Colin, P.;Morice, M.C.;Monassier, J.P.;Ider, O.;Dubois-Rande, J.L.P.;Unterseeh, T.;Lebreton, H.;Beard, T.;Blanchard, D.;Grollier, G.;Malquarti, V.;Staat, P.;Sudre, A.;Hansson, M.J.;Elmer, E.;Boussaha, I.;Jossan, C.;Torner, A.;Claeys, M.;Garcia-Dorado, D.;Ovize, M.; |
American Heart Journal |
2015-06-01 |
查看 |
| Rationale and design of the Cyclosporine to ImpRove Clinical oUtcome inST-elevation myocardial infarction patients (the CIRCUS trial) |
the CIRCUS Study Investigators;Mewton, N.;Cung, T.T.;Morel, O.;Cayla, G.;Bonnefoy-Cudraz, E.;Rioufol, G.;Angoulvant, D.;Guerin, P.;Elbaz, M.;Delarche, N.;Coste, P.;Vanzetto, G.;Metge, M.;Aupetit, J.F.;Jouve, B.;Motreff, P.;Tron, C.;Labeque, J.N.;Steg, P.G.;Cottin, Y.;Range, G.;Clerc, J.;Coussement, P.;Prunier, F.;Moulin, F.;Roth, O.;Belle, L.;Dubois, P.;Barragan, P.;Gilard, M.;Piot, C.;Colin, P.;Morice, M.C.;Monassier, J.P.;Ider, O.;Dubois-Rande, J.L.P.;Unterseeh, T.;Lebreton, H.;Beard, T.;Blanchard, D.;Grollier, G.;Malquarti, V.;Staat, P.;Sudre, A.;Hansson, M.J.;Elmer, E.;Boussaha, I.;Jossan, C.;Torner, A.;Claeys, M.;Garcia-Dorado, D.;Ovize, M.; |
American Heart Journal |
2015-06-01 |
查看 |
| Early P2Y"1"2 inhibition in ST-segment elevation myocardial infarction:Bridging the gap |
Alexopoulos, D.;Bhatt, D.L.;Hamm, C.W.;Steg, P.G.;Stone, G.W.; |
American Heart Journal |
2015-07-01 |
查看 |
|
|
|
